Form 425 REGIONAL HEALTH PROPERTI Filed by: REGIONAL HEALTH PROPERTIES, INC
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Filed by: Regional Health Properties, Inc.
Pursuant to Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 13e-4(c), Rule 14d-2(b) and Rule 14a-12
under the Securities Exchange Act of 1934
Subject Company: Regional Health Properties, Inc.
Commission File Number: 001-33135
On July 5, 2022, Regional Health Properties, Inc. issued the following notice via email and postal mail to certain holders of its common stock in order to encourage them to vote in its reconvened Special Meeting of Shareholders on July 25, 2022.
**** IMPORTANT REMINDER ****
Dear «INVESTOR NAME»,
By now, you should have received your proxy material for the 2022 Regional Health Properties, Inc. Special Meeting, which was originally scheduled to be held on March 28, 2022. The meeting has been adjourned until July 25, 2022 to allow for more time to solicit additional votes. You are receiving this reminder letter because your votes were not yet processed at the time that this letter was mailed. If you have already voted, we would like to thank you for your vote.
****PLEASE VOTE TODAY****
Your Board recommends that you vote FOR proposals 1 and 2. Even if you plan on attending the meeting, we urge you to vote your shares now, so they can be tabulated prior to the meeting.
YOUR VOTE IS EXTREMELY IMPORTANT AND EVERY SHARE COUNTS
The fastest and easiest way to vote is via telephone or e-mail. You can simply text or email our proxy solicitation firm how you would like to vote. Please see contact details below.
WE URGE YOU TO EXERCISE YOUR RIGHT TO VOTE TODAY
If you have questions or need help voting your shares, please contact our proxy solicitation firm below.
Thank you for your investment in Regional Health Properties, Inc. and for taking the time to vote your shares.
Brent Morrison, CFA
President & Chief Executive Officer
No Offer or Solicitation
This communication is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended.
Additional Information about the Exchange Offer and Where to Find It
Regional Health Properties, Inc. (RHE) filed a registration statement and definitive proxy statement/prospectus in connection with the proposed transaction with the Securities and Exchange Commission (the SEC). RHE also filed with the SEC a joint statement on Schedule TO/13E-3 for the proposed transaction. RHE has amended or supplemented these filings and intends to file other relevant documents with the SEC regarding the proposed transaction. This document is not a substitute for the definitive proxy statement/prospectus or registration statement or any other document that RHE may file with the SEC. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THESE DOCUMENTS CAREFULLY AND IN THEIR ENTIRETY.
Participants in the Solicitation
RHE and certain of its directors and executive officers may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction. Information about the directors and executive officers of RHE, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in RHEs proxy statement for its 2021 Annual Meeting of Shareholders, which was filed with the SEC on October 22, 2021, and RHEs Annual Report on Form 10-K for the fiscal year ended December 31, 2021, which was filed with the SEC on February 22, 2022. Investors may obtain additional information regarding the interests of those persons and other persons who may be deemed participants in the proposed transaction by reading the definitive proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the proposed transaction when such materials become available. Investors should read the definitive proxy statement/prospectus carefully before making any voting or investment decisions. You may obtain free copies of these documents from RHE using the sources indicated above.
- Nasdaq, S&P 500 retreat as rate hike fears cool stock rally
- Disney (DIS) Stock Gains on Disney+ Beat and Raised Prices, Earns Upgrade to Buy
- Sonos Plunges as Weak Demand Prompts Outlook Cut, Analyst Seeks to See More Stabilization in Business
- AppLovin (APP) Shares Drop After Earnings Miss, Analyst Sees Growing Risks
- Bumble (BMBL) Falls on Slashed Revenue Guidance, Q2 Results Seen as 'Solid'
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- InnoCare Announces Acceptance of Supplemental New Drug Application for Orelabrutinib in Relapsed or Refractory Marginal Zone Lymphoma in China
- Daqo New Energy Issues Its 2021 Environmental, Social and Governance (ESG) Report
- Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call on August 18, 2022
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!